XTRACT ONE TECHNOLOGIES INC (XTRA.CA) Fundamental Analysis & Valuation

TSX:XTRA • CA98422Q1063

Current stock price

0.46 CAD
0 (0%)
Last:

This XTRA.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. XTRA.CA Profitability Analysis

1.1 Basic Checks

  • XTRA had negative earnings in the past year.
  • In the past year XTRA has reported a negative cash flow from operations.
  • In the past 5 years XTRA always reported negative net income.
  • XTRA had a negative operating cash flow in each of the past 5 years.
XTRA.CA Yearly Net Income VS EBIT VS OCF VS FCFXTRA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M

1.2 Ratios

  • XTRA's Return On Assets of -37.13% is on the low side compared to the rest of the industry. XTRA is outperformed by 84.62% of its industry peers.
  • XTRA has a Return On Equity of -61.88%. This is comparable to the rest of the industry: XTRA outperforms 53.85% of its industry peers.
Industry RankSector Rank
ROA -37.13%
ROE -61.88%
ROIC N/A
ROA(3y)-60.36%
ROA(5y)-86.91%
ROE(3y)-100.39%
ROE(5y)-121.9%
ROIC(3y)N/A
ROIC(5y)N/A
XTRA.CA Yearly ROA, ROE, ROICXTRA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600

1.3 Margins

  • Looking at the Gross Margin, with a value of 59.05%, XTRA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • The Profit Margin and Operating Margin are not available for XTRA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XTRA.CA Yearly Profit, Operating, Gross MarginsXTRA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. XTRA.CA Health Analysis

2.1 Basic Checks

  • XTRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for XTRA has been increased compared to 1 year ago.
  • XTRA has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, XTRA has a worse debt to assets ratio.
XTRA.CA Yearly Shares OutstandingXTRA.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
XTRA.CA Yearly Total Debt VS Total AssetsXTRA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of -1.67, we must say that XTRA is in the distress zone and has some risk of bankruptcy.
  • XTRA has a worse Altman-Z score (-1.67) than 84.62% of its industry peers.
  • XTRA has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.04, XTRA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z -1.67
ROIC/WACCN/A
WACC9.6%
XTRA.CA Yearly LT Debt VS Equity VS FCFXTRA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 2.55 indicates that XTRA has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.55, XTRA is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
  • XTRA has a Quick Ratio of 2.15. This indicates that XTRA is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of XTRA (2.15) is better than 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 2.55
Quick Ratio 2.15
XTRA.CA Yearly Current Assets VS Current LiabilitesXTRA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. XTRA.CA Growth Analysis

3.1 Past

  • The earnings per share for XTRA have decreased strongly by -25.00% in the last year.
  • Looking at the last year, XTRA shows a decrease in Revenue. The Revenue has decreased by -0.90% in the last year.
  • XTRA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 46.26% yearly.
EPS 1Y (TTM)-25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-0.9%
Revenue growth 3Y56.42%
Revenue growth 5Y46.26%
Sales Q2Q%69.87%

3.2 Future

  • Based on estimates for the next years, XTRA will show a very strong growth in Earnings Per Share. The EPS will grow by 34.01% on average per year.
  • Based on estimates for the next years, XTRA will show a very strong growth in Revenue. The Revenue will grow by 59.57% on average per year.
EPS Next Y38.8%
EPS Next 2Y34.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year71.1%
Revenue Next 2Y59.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
XTRA.CA Yearly Revenue VS EstimatesXTRA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
XTRA.CA Yearly EPS VS EstimatesXTRA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2024 2025 2026 2027 -0.05 -0.1 -0.15

More info and screens

Find the best growth stocksShow best growing peers

1

4. XTRA.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for XTRA. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XTRA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XTRA.CA Price Earnings VS Forward Price EarningsXTRA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XTRA.CA Per share dataXTRA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04 0.06

4.3 Compensation for Growth

  • A more expensive valuation may be justified as XTRA's earnings are expected to grow with 34.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.01%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. XTRA.CA Dividend Analysis

5.1 Amount

  • XTRA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

XTRA.CA Fundamentals: All Metrics, Ratios and Statistics

XTRACT ONE TECHNOLOGIES INC

TSX:XTRA (4/22/2026, 7:00:00 PM)

0.46

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)03-04
Earnings (Next)06-03
Inst Owners0.64%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap119.55M
Revenue(TTM)17.21M
Net Income(TTM)-11.85M
Analysts82.5
Price Target1.05 (128.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.96%
Min EPS beat(2)1.96%
Max EPS beat(2)1.96%
EPS beat(4)3
Avg EPS beat(4)-22.55%
Min EPS beat(4)-96.08%
Max EPS beat(4)1.96%
EPS beat(8)7
Avg EPS beat(8)1.96%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.45%
Min Revenue beat(2)-2.21%
Max Revenue beat(2)1.31%
Revenue beat(4)1
Avg Revenue beat(4)-15.37%
Min Revenue beat(4)-34.03%
Max Revenue beat(4)1.31%
Revenue beat(8)3
Avg Revenue beat(8)-7.25%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.65%
PT rev (3m)-4.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-20%
EPS NY rev (3m)-20%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.85%
Revenue NY rev (1m)-4.58%
Revenue NY rev (3m)-4.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.95
P/FCF N/A
P/OCF N/A
P/B 6.24
P/tB 7.89
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.07
BVpS0.07
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -37.13%
ROE -61.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.05%
FCFM N/A
ROA(3y)-60.36%
ROA(5y)-86.91%
ROE(3y)-100.39%
ROE(5y)-121.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.15%
Cap/Sales 0.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.55
Quick Ratio 2.15
Altman-Z -1.67
F-Score4
WACC9.6%
ROIC/WACCN/A
Cap/Depr(3y)20.53%
Cap/Depr(5y)19.86%
Cap/Sales(3y)3.35%
Cap/Sales(5y)13.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y38.8%
EPS Next 2Y34.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.9%
Revenue growth 3Y56.42%
Revenue growth 5Y46.26%
Sales Q2Q%69.87%
Revenue Next Year71.1%
Revenue Next 2Y59.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year47.88%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.13%
OCF growth 3YN/A
OCF growth 5YN/A

XTRACT ONE TECHNOLOGIES INC / XTRA.CA Fundamental Analysis FAQ

What is the fundamental rating for XTRA stock?

ChartMill assigns a fundamental rating of 3 / 10 to XTRA.CA.


Can you provide the valuation status for XTRACT ONE TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 1 / 10 to XTRACT ONE TECHNOLOGIES INC (XTRA.CA). This can be considered as Overvalued.


Can you provide the profitability details for XTRACT ONE TECHNOLOGIES INC?

XTRACT ONE TECHNOLOGIES INC (XTRA.CA) has a profitability rating of 1 / 10.


How financially healthy is XTRACT ONE TECHNOLOGIES INC?

The financial health rating of XTRACT ONE TECHNOLOGIES INC (XTRA.CA) is 4 / 10.


Can you provide the expected EPS growth for XTRA stock?

The Earnings per Share (EPS) of XTRACT ONE TECHNOLOGIES INC (XTRA.CA) is expected to grow by 38.8% in the next year.